Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls. - Wikidata - awgldk - TriplyDB

Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls.

Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls.

http://www.wikidata.org/entity/Q35562079

about

Intestinal permeability defects: is it time to treat?The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders Brain-gut axis: from basic understanding to treatment of IBS and related disorders Relationship between patterns of alcohol consumption and gastrointestinal symptoms among patients with irritable bowel syndrome.Standardising the lactulose mannitol test of gut permeability to minimise error and promote comparability.Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function.Validating biomarkers of treatable mechanisms in irritable bowel syndrome Clinical characteristics associated with postoperative intestinal epithelial barrier dysfunction in children with congenital heart disease.Simultaneous gas-chromatographic urinary measurement of sugar probes to assess intestinal permeability: use of time course analysis to optimize its use to assess regional gut permeability.Assessment of the Effect of Intestinal Permeability Probes (Lactulose And Mannitol) and Other Liquids on Digesta Residence Times in Various Segments of the Gut Determined by Wireless Motility Capsule: A Randomised Controlled Trial.Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea.Corticosterone mediates stress-related increased intestinal permeability in a region-specific manner.Drug development for the irritable bowel syndrome: current challenges and future perspectives Gastrointestinal permeability in patients with irritable bowel syndrome assessed using a four probe permeability solution.Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome.(13) C mannitol as a novel biomarker for measurement of intestinal permeability Interactions between zinc deficiency and environmental enteropathy in developing countries.Gluten-induced symptoms in diarrhea-predominant irritable bowel syndrome are associated with increased myosin light chain kinase activity and claudin-15 expression.Complementary and alternative medicines in irritable bowel syndrome: an integrative view.Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study.Potential mechanisms of effects of serum-derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndrome.Intestinal barrier function in health and gastrointestinal disease.The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet.Intestinal barrier: A gentlemen's agreement between microbiota and immunity.Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.Methods to determine intestinal permeability and bacterial translocation during liver disease.Early weaning stress induces chronic functional diarrhea, intestinal barrier defects, and increased mast cell activity in a porcine model of early life adversity.Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome.Combat-training increases intestinal permeability, immune activation and gastrointestinal symptoms in soldiers.Constipation-Predominant Irritable Bowel Syndrome Females Have Normal Colonic Barrier and Secretory Function.Esophageal and Small Intestinal Mucosal Integrity in Eosinophilic Esophagitis and Response to an Elemental Diet Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism.Increased subsequent risk of erectile dysfunction in patients with irritable bowel syndrome: a nationwide population-based cohort study.Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders.Differential trafficking of saccharidic probes following aspirin in clinical tests of intestinal permeability in young healthy women.The effect of aspirin and smoking on urinary excretion profiles of lactulose and mannitol in young women: toward a dynamic, aspirin augmented, test of gut mucosal permeability.

P2860

Q24629228-466319F5-6C88-486D-84DA-DEC6F14E7203 Q26771888-21ACC7FC-165A-44A4-8DFE-2E49E27A27A0 Q26777279-689966B5-4854-45EE-8652-0F9BB9B6FD51 Q27024801-6A9961DA-5A2C-4A9E-B8EE-C22731A6FC4B Q33456815-8C12F17A-9F85-4C9E-BA92-86525149E221 Q33717298-77B222ED-EA2B-4145-9767-2E57A4E9F754 Q34131127-D6E58865-DB1C-4A5A-87E6-52E47A4352DB Q34324881-27D32968-4214-4591-8568-029958309B8D Q34577283-D9C1D848-4DB5-462B-935F-C55F9A27ECF5 Q34859899-1205E6E3-B848-4AC6-9241-601410BD3EC6 Q35118493-63607686-A090-44BC-B585-83E19DB94640 Q35858688-CC6D3640-39B2-487B-898A-3CE5A8562412 Q36494385-F65739C2-7945-49DB-857C-A9E983CD2539 Q36573670-65C8EF68-F367-4941-A6D0-69BE214680FE Q36579818-2F5A0D2F-406D-4441-83F3-F6BCDA218A31 Q36674027-7C56B6E6-A717-4BF3-9425-0D61B8838896 Q36780412-5B8EDC54-6609-4339-A67C-10E21EE30720 Q36970524-2F9ECDAD-A11B-4D88-9EBB-4273B6AD283B Q37037330-4F0DDC44-2493-4602-AC7B-6ACE06F13736 Q37446572-27BFF0E0-32A2-4D99-A087-5CE79C6E625B Q37559869-5E6BF95D-73B3-4412-8D6C-236E8269E2E4 Q37581337-92BBE76D-09C9-41ED-9803-FE08E1E680AB Q37698552-272C3BC9-6A12-4458-82CA-C991A49C8273 Q37699665-FBB66072-B41C-46F6-BE28-A56A15F5A9F3 Q38009940-F120E530-A536-434E-B505-CF264C23C9AC Q38016781-39947A02-EB09-4F4D-B23E-857134830A24 Q38217233-B15B2CA4-DFEB-4919-9C86-414D91B108EB Q38275041-6D55905C-1CE9-4B98-AC0A-87F9220B9C83 Q38321290-30CECFC6-746B-4AB1-A100-6D212C648B9F Q38749341-D6588B82-4CA2-43B2-8140-BBAC2C82D455 Q38810529-84551694-B20E-42E5-A8DC-16DEF42EBB09 Q39463126-CD70ADB0-1098-489B-AD95-6C21BFC8A07B Q40963516-475553B3-ED51-4A21-BD71-6ACC649BD79A Q41126753-03DC0532-E9D0-4A83-8323-CA85B9F2CFD1 Q44572735-0746F378-A47E-4C9E-92D1-6AAF44295DDA Q45212489-3B1C12AE-6B7B-4DFA-948C-F9FEA935C609 Q48270830-C168A03F-CEDB-4171-8C77-0BB214C7326A Q51204269-A52CB851-29BB-42CD-9C69-D241E36A9C04 Q51327931-ACE6F4D4-2839-48E6-AFBE-C77621314B33

P2860

Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls.

http://www.wikidata.org/entity/Q35562079

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Urine sugars for in vivo gut p ...... yndrome-diarrhea and controls.

@ast

Urine sugars for in vivo gut p ...... yndrome-diarrhea and controls.

@en

type

label

Urine sugars for in vivo gut p ...... yndrome-diarrhea and controls.

@ast

Urine sugars for in vivo gut p ...... yndrome-diarrhea and controls.

@en

prefLabel

Urine sugars for in vivo gut p ...... yndrome-diarrhea and controls.

@ast

Urine sugars for in vivo gut p ...... yndrome-diarrhea and controls.

@en

P1433

Q35562079-F9B2C133-DFA7-44B5-A44C-8AE824FAEBF5

P1476

Q35562079-D1095D65-12F8-4D08-974F-B7B678BA3C8A

P2093

Q35562079-60BF1AAE-9CF6-4347-8D3C-A3DEFD30A0FE

Q35562079-7920128B-166F-4801-BD36-380C3FBD5D30

Q35562079-81FA33B4-3BEA-436B-B138-2992CD308DCD

Q35562079-B756BF27-D65B-4258-9A23-9291922C0690

Q35562079-B9D008BB-384F-48A9-BB8D-D1BD7B097489

Q35562079-C68104BE-1E6F-4BFF-8279-68AB88A1668C

Q35562079-CD8BD2C4-3716-42DA-8DCB-4BA37F23518F

Q35562079-EA4D761A-61D3-4F16-BB18-7347EB6AB6CF

P2860

Q35562079-099F5B00-A840-4750-9222-5C6D5C1EC046

Q35562079-0A07CD78-5123-4676-A821-49F175ED8875

Q35562079-0E3F04A5-C179-4477-A505-8713ABAC7E79

Q35562079-173A627E-8E4C-4323-BD39-612B4B6ED794

Q35562079-2EBFE367-FBD2-47EE-A462-F022F3F9A571

Q35562079-36B927F7-A058-4B73-838E-B49183ECB08F

Q35562079-46091731-EB8B-4D26-BFBF-E4E9EB1CE628

Q35562079-48BE265A-3689-4404-90E8-2AADFE7B27D8

Q35562079-49063A82-F438-44A6-8E46-662268139D82

Q35562079-512EF6E6-394E-4AD5-B530-FCD4BA22D3B9

P304

Q35562079-BABA0AA5-FB71-475C-818B-743596F25712

P31

Q35562079-A9053566-2AB8-44B0-8B24-4AC0601D956E

P356

Q35562079-04518FF8-BCF0-4066-A3F9-BE499B653AFE

P433

Q35562079-17EC436B-7B9B-4973-8DDE-6C20252C288E

P478

Q35562079-462E3C89-0201-4788-B7AD-CAA07DDBDD32

P50

Q35562079-1168C4B7-5E2B-4970-A5B3-1694CA7F9A29

Q35562079-B5BF55AA-2B92-406C-A44E-AD1F431E7247

P577

Q35562079-713931B9-E7A4-49DC-AFA2-206F3CF8DA5E

P5875

Q35562079-06E12615-DAED-4724-BD72-41F918CC394C

P698

Q35562079-96FACF69-5270-46F2-8114-EB5AAA1906F7

P921

Q35562079-AE752430-1FE3-4A89-8A3B-DE060E37F62F

P932

Q35562079-2E0457BC-954A-40C0-B174-476E563F1AE8

P356

AJPGI.00168.2011

P1433

American Journal of Physiology - Gastrointestinal and Liver Physiology

P1476

Urine sugars for in vivo gut p ...... yndrome-diarrhea and controls.

@en

P2093

Archana S Rao

http://www.w3.org/2001/XMLSchema#string

Banny S Wong

http://www.w3.org/2001/XMLSchema#string

Deborah J Eckert

http://www.w3.org/2001/XMLSchema#string

Duane D Burton

http://www.w3.org/2001/XMLSchema#string

Irene Busciglio

http://www.w3.org/2001/XMLSchema#string

Jesse Lamsam

http://www.w3.org/2001/XMLSchema#string

Michael Ryks

http://www.w3.org/2001/XMLSchema#string

Ravinder Singh

http://www.w3.org/2001/XMLSchema#string

P2860

The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome

Rifaximin therapy for patients with irritable bowel syndrome without constipation

Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion.

Effects of timing, sex, and age on site-specific gastrointestinal permeability testing in children and adults.

MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome.

Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation.

Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes.

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review.

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

Dynamics of mucosal permeability and inflammation in collagenous colitis before, during, and after loop ileostomy.

P304

G919-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPGI.00168.2011

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

301

http://www.w3.org/2001/XMLSchema#string

P50

Alan R. Zinsmeister

Michael Camilleri

P577

2011-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51566111

http://www.w3.org/2001/XMLSchema#string

P698

21836056

http://www.w3.org/2001/XMLSchema#string

P921

Afọ ọsịsa

P932

3220318

http://www.w3.org/2001/XMLSchema#string